Enlivex Therapeutics Ltd (ENLV)
1.62
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
1.64
+0.02
(+1.23%)
After-Hours: 20:00
Enlivex Therapeutics 1 Year Total Returns (Daily): -42.14% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -42.14% |
May 02, 2024 | -41.94% |
May 01, 2024 | -42.91% |
April 30, 2024 | -41.20% |
April 29, 2024 | -41.55% |
April 26, 2024 | -51.84% |
April 25, 2024 | -48.03% |
April 24, 2024 | -47.18% |
April 23, 2024 | -55.41% |
April 22, 2024 | -57.09% |
April 19, 2024 | -54.79% |
April 18, 2024 | -51.72% |
April 17, 2024 | -48.70% |
April 16, 2024 | -50.17% |
April 15, 2024 | -55.33% |
April 12, 2024 | -45.33% |
April 11, 2024 | -34.64% |
April 10, 2024 | 30.49% |
April 09, 2024 | 42.66% |
April 08, 2024 | 43.36% |
April 05, 2024 | 52.67% |
April 04, 2024 | 49.80% |
April 03, 2024 | 16.16% |
April 02, 2024 | 10.99% |
April 01, 2024 | 9.89% |
Date | Value |
---|---|
March 28, 2024 | 9.86% |
March 27, 2024 | 9.35% |
March 26, 2024 | 9.52% |
March 25, 2024 | 15.13% |
March 22, 2024 | 1.38% |
March 21, 2024 | -1.10% |
March 20, 2024 | 9.84% |
March 19, 2024 | 14.33% |
March 18, 2024 | 17.42% |
March 15, 2024 | 14.48% |
March 14, 2024 | 16.06% |
March 13, 2024 | 19.78% |
March 12, 2024 | 14.88% |
March 11, 2024 | 1.93% |
March 08, 2024 | 3.13% |
March 07, 2024 | -12.45% |
March 06, 2024 | -13.62% |
March 05, 2024 | -17.77% |
March 04, 2024 | -13.20% |
March 01, 2024 | -18.73% |
February 29, 2024 | -22.38% |
February 28, 2024 | -27.00% |
February 27, 2024 | -20.83% |
February 26, 2024 | -21.88% |
February 23, 2024 | -22.05% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.62%
Minimum
Sep 23 2020
294.2%
Maximum
Sep 23 2019
-7.35%
Average
-34.12%
Median
May 23 2019
1 Year Total Returns (Daily) Benchmarks
Compugen Ltd | 235.5% |
Pluri Inc | -27.40% |
BioLine Rx Ltd | -41.88% |
Can Fite Biofarma Ltd | 8.85% |
BiomX Inc | 42.19% |